213 related articles for article (PubMed ID: 9440907)
1. One-year results of growth hormone treatment of short stature in Prader-Willi syndrome.
Hauffa BP
Acta Paediatr Suppl; 1997 Nov; 423():63-5. PubMed ID: 9440907
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
[TBL] [Abstract][Full Text] [Related]
3. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Ritzén EM
Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone treatment on growth and body composition in Prader-Willi syndrome: a preliminary report. The Swedish National Growth Hormone Advisory Group.
Lindgren AC; Hagenäs L; Müller J; Blichfeldt S; Rosenborg M; Brismar T; Ritzén EM
Acta Paediatr Suppl; 1997 Nov; 423():60-2. PubMed ID: 9401542
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
[TBL] [Abstract][Full Text] [Related]
6. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
8. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
9. Effect of 6 months of growth hormone treatment in young children with Prader-Willi syndrome.
Eiholzer U; Weber R; Stutz K; Steinert H
Acta Paediatr Suppl; 1997 Nov; 423():66-8. PubMed ID: 9401543
[TBL] [Abstract][Full Text] [Related]
10. Physical effects of growth hormone treatment in children with Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
Acta Paediatr Suppl; 1999 Dec; 88(433):112-4. PubMed ID: 10626559
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
12. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
14. The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome.
Höybye C; Frystyk J; Thorén M
Growth Horm IGF Res; 2003 Oct; 13(5):269-74. PubMed ID: 12932748
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after 4 years of therapy.
Eiholzer U; l'Allemand D
Horm Res; 2000; 53(4):185-92. PubMed ID: 11044802
[TBL] [Abstract][Full Text] [Related]
16. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.
Lin HY; Lin SP; Tsai LP; Chao MC; Chen MR; Chuang CK; Huang CY; Tsai FJ; Chou IC; Chiu PC; Huang CH; Yen JL; Lin JL; Kuo PL
J Chin Med Assoc; 2008 Jun; 71(6):305-9. PubMed ID: 18567561
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
[TBL] [Abstract][Full Text] [Related]
19. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
20. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
Kriström B; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
